[ad_1]
Dean of the Faculty of Medicine of Sakarya University Prof. Dr. Oguz Karabayır, as well as the numerous clinical research studies conducted in Turkey such as on the Sakarya Pfizer vaccine, the vaccine belonging to biontech was conducted on 40 volunteers, he said.
“THE RESULTS ARE SATISFACTORY”
Stating that vaccines abroad have reached the human trial stage, Karabay said: “Very satisfactory results have been achieved in the vaccine from Pfizer – BioNTech company. In addition, the vaccine has reached numerous clinical trials in our country. “It will apply to people in the near future.”
“APPLIED TO 40 VOLUNTEERS”
According to the statement on the Sakarya University website, Karabay claimed that the vaccine belonging to Pfizer – BioNTech was applied to healthcare professionals and some citizens, many of whom were professors, in Sakarya.
* Pfizer – The BioNTech vaccine was administered to 40 volunteers.
* Volunteers receiving vaccinations are followed by the adult vaccination outpatient clinic within the SEAH infection service.
* Our vaccinated patients will be followed by our vaccination polyclinic for a long time.
“THE MOST EFFECTIVE WAY TO VACCINE”
Karabay, who evaluated vaccine studies around the world and spoke about the role of the vaccine, said:
* One of the most effective ways to get rid of an infectious disease is vaccination.
* If there is an effective vaccine against a disease factor, it is very easy to fight this disease.
* A vaccine that will be provided for the coronaviruses causing the Covid-19 outbreak will be very helpful.
* M-RNA (messenger RNA) is a single-stranded RNA sequence that is read by the ribosome within the cell and is used to synthesize proteins.
* The target cell uses this RNA to produce the protein of interest. The immune system triggers defense processes against this foreign protein.
It may interest you
It may interest you
[ad_2]
